ArticleBMC cancer2018

Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.

Wan-Ling Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.